Aurinia Pharmaceuticals Inc (AUPH)

NASDAQ HEALTHCARE
$15.28 -4.74% RSI 46 Neutral Add Alert

Moving Averages

SMA 200
$13.05
Price above

Company Profile

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and markets therapies to treat various diseases with unmet medical needs in Japan and China. The company is headquartered in Victoria, Canada.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$2.12B
P/E Ratio
7.71
EPS
$2.07
Beta
1.523
Dividend Yield
0.00%
52-Week High
$16.54
52-Week Low
$7.29

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 57.0
VRTX
Vertex Pharmaceuticals Inc
RSI 41.0
CRSP
CRISPR Therapeutics AG
RSI 50.0
MRNA
Moderna Inc
RSI 36.0
VKTX
Viking Therapeutics Inc
RSI 38.0
SRPT
Sarepta Therapeutics Inc
RSI 51.0

Data last updated: April 11, 2026 at 5:24 AM EDT

Track AUPH for free

Get e-mail RSI alerts when Aurinia Pharmaceuticals Inc enters oversold or overbought territory. Free forever.

Add Alert